glp 1 anti obesity What's New in Treatment? GLP−1 receptor agonists for the

Even transdermal delivery is being explored through GLP-1 patches like Onmorlo

Short-chain fatty acids protect against high-fat diet-induced obesity via a PPAR-dependent switch from lipogenesis to fat oxidation

Traditionally GLP-1(9-36) was considered inactive, however more recent studies indicate that GLP-1(9-36) can contribute to inhibiting glucagon secretion by inhibiting voltage-gated calcium channels through a GPCR mechanism, an effect which reduces the number of glucagon containing vesicles that are available for exocytosis, thereby contributing the the decrease in glucagon secretion (Figure 1)(Zheng et al, 2024)

These aim to lighten and brighten the skin and may also smooth hollows that can cause shadows

Traditional mesotherapy has been used for decades and used for facial rejuvenations, weight loss, cellulitis and other localized problems

Hui Q, Jin Z, Li X, Liu C, Wang X